Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFIRINOX and Chemoradiotherapy in Locally Advanced Pancreatic Cancer
NCT01397019Phase 2Completed
- Sponsor
- Pfeiffer Pharmaceuticals
- Start
- Apr 2011
- Primary completion
- Feb 2016
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, irinotecan, fluorouracil, folinic acid, capecitabine in pancreatic cancer (PC), sponsored by Pfeiffer Pharmaceuticals. Started Apr 2011; status: completed.
02
Drugs
oxaliplatinirinotecanfluorouracilfolinic acidcapecitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01397019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01397019.